Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics
Molecules · 12.05.2024 · 29 (10) · 2277
DOI: 10.3390/molecules29102277 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 12.05.2024. Verfasst von Sijongesonke Peter und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Fort Hare, Alice 5700, South Africa. Hauptthemen laut MEDLINE: Thymol, Cymenes, Anti-Bacterial Agents, Antineoplastic Agents. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: South African Medical Research Council, University of Fort Hare, Sasol Foundation, South African Medical Research Foundation, National Research Foundation, and Govan Mbeki Research and Development Ce….
Abstract (Originalsprache)
Cancer is ranked among lethal diseases globally, and the increasing number of cancer cases and deaths results from limited access to effective therapeutics. The use of plant-based medicine has been gaining interest from several researchers. Carvacrol and its isomeric compound, thymol, are plant-based extracts that possess several biological activities, such as antimalarial, anticancer, antifungal, and antibacterial. However, their efficacy is compromised by their poor bioavailability. Thus, medicinal scientists have explored the synthesis of hybrid compounds containing their pharmacophores to enhance their therapeutic efficacy and improve their bioavailability. Hence, this review is a comprehensive report on hybrid compounds containing carvacrol and its isomer, thymol, with potent anticancer and antibacterial agents reported between 2020 and 2024. Furthermore, their structural activity relationship (SAR) and recommended future strategies to further enhance their therapeutic effects will be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Fort Hare, Alice 5700, South Africa.
ORCID-Profile: Sijongesonke Peter, Namhla Sotondoshe, Blessing A Aderibigbe
Förderung
- South African Medical Research Council
- University of Fort Hare, Sasol Foundation, South African Medical Research Foundation, National Research Foundation, and Govan Mbeki Research and Development Ce…
Zitieren
APA
Peter, S., Sotondoshe, N., & Aderibigbe, B. A. (2024). Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics. Molecules, 29(10), 2277. https://doi.org/10.3390/molecules29102277
Vancouver
Peter S, Sotondoshe N, Aderibigbe BA. Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics. Molecules. 2024;29(10):2277. doi:10.3390/molecules29102277
BibTeX
@article{Peter2024,
author = {Peter, Sijongesonke and Sotondoshe, Namhla and Aderibigbe, Blessing A},
title = {Carvacrol and Thymol Hybrids: Potential Anticancer and Antibacterial Therapeutics},
journal = {Molecules},
year = {2024},
volume = {29},
number = {10},
pages = {2277},
doi = {10.3390/molecules29102277}
}
EUVIMED